Quick Dispatch:
Your foxo4-dri senolytic human trial Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your foxo4-dri senolytic human trial Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell ships.
Need Help?
Questions about foxo4-dri senolytic human trial Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for foxo4-dri senolytic human trial Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell in your area.
Development of a novel senolytic by precise disruption of FOXO4-p53 complex
21.59
Frontiers
28.86
Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis
21.98
Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment
26.84
foxo4-dri senolytic peptide human trial 2024 Buy Epithalon (50mg) | 99% Purity
29.79
Frontiers
21.90
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI
29.63
